Rep. DeRossett offered the following resolution:

            House Resolution No. 189

A resolution to urge the United States Food and Drug Administration not to approve Plan B®, “the morning-after pill,” as an over-the-counter medication.

Whereas, The United States Food and Drug Administration (FDA) approved Plan B®, which is often referred to as "the morning-after pill," for prescription use on July 28, 1999; and

Whereas, Plan B® is marketed as an emergency contraceptive that can be used to prevent pregnancy following unprotected intercourse or a known or suspected contraceptive failure; and

Whereas, An advisory committee to the FDA has recently recommended that the FDA designate Plan B®, the morning-after pill, as an over-the-counter (nonprescription) medication; and

Whereas, Plan B® should not be legalized and sold without a prescription.  Morning-after pills are not birth-control pills.  It is an abortion-inducing drug.  It is designed to induce abortions within 72 hours of intercourse; and

Whereas, Another critically important issue in discussions of the morning-after pill is its serious health implications.  This medication is known to cause a number of side effects, such as nausea, vomiting, breast tenderness, infertility and blood-clot formation; and

Whereas, Birth-control pills are prescription medications for a valid reason.  Taken in sufficient doses or in combination with certain medicines or medical conditions, estrogen and progesterone have been known to cause cancer, heart disease, reproductive complications, and other adverse conditions.  Women who take birth-control pills must visit their physician once a year at a minimum; and

Whereas, Women and their unborn children should be protected by FDA policies.  The proposal to make Plan B®, the morning-after pill, available as an over-the-counter medication runs counter to that goal.  The United States Food and Drug Administration should not approve the sale of these abortion-inducing chemicals to thousands of women who have not been adequately informed of the consequences; now, therefore, be it

Resolved by the House of Representatives, That we urge the United States Food and Drug Administration not to approve Plan B®, “the morning-after pill,” as an over-the-counter (nonprescription) medication; and be it further

Resolved, That copies of this resolution be transmitted to the United States Food and Drug Administration, the President of the United States Senate, the Speaker of the United States House of Representatives, and the members of the Michigan congressional delegation.